Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Mol Pharm ; 21(6): 2781-2794, 2024 Jun 03.
Artigo em Inglês | MEDLINE | ID: mdl-38676649

RESUMO

The nanocrystal (NC) technology has become one of the most commonly used strategies for the formulation of poorly soluble actives. Given their large specific surface, NCs are mainly used to enhance the oral absorption of poorly soluble actives. Differently from conventional nanoparticles, which require the use of carrier materials and have limited drug loadings, NCs' drug loading approaches 100% since they are formed of the pure drug and surrounded by a thin layer of a stabilizer. In this work, we report the covalent decoration of curcumin NCs with folic acid (FA) using EDC/NHS chemistry and explore the novel systems as highly loaded "Trojan horses" to target cancer cells. The decorated NCs demonstrated a remarkable improvement in curcumin uptake, exhibiting enhanced growth inhibition in cancer cells (HeLa and MCF7) while sparing healthy cells (J774A.1). Cellular uptake studies revealed significantly heightened entry of FA-decorated NCs into cancer cells compared to unmodified NCs while also showing reduced uptake by macrophages, indicating a potential for prolonged circulation in vivo. These findings underline the potential of NC highly loaded nanovectors for drug delivery and, in particular, for cancer therapies, effectively targeting folate receptor-overexpressing cells while evading interception by macrophages, thus preserving their viability and offering a promising avenue for precise and effective treatments.


Assuntos
Curcumina , Ácido Fólico , Nanopartículas , Ácido Fólico/química , Humanos , Nanopartículas/química , Curcumina/farmacologia , Curcumina/química , Curcumina/farmacocinética , Curcumina/administração & dosagem , Animais , Células MCF-7 , Células HeLa , Sistemas de Liberação de Medicamentos/métodos , Camundongos , Portadores de Fármacos/química , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Antineoplásicos/farmacologia , Antineoplásicos/química , Antineoplásicos/administração & dosagem , Antineoplásicos/farmacocinética , Neoplasias/tratamento farmacológico , Neoplasias/patologia , Sobrevivência Celular/efeitos dos fármacos , Linhagem Celular Tumoral
2.
J Pharm Sci ; 112(12): 3233-3239, 2023 12.
Artigo em Inglês | MEDLINE | ID: mdl-37716530

RESUMO

This study aimed to investigate the polymorphism of 1-(4-acetamide-benzenesulfonyl)-benzimidazole (PABZI), a newly developed compound with significant activity against Trypanosoma cruzi, the parasite which causes American trypanosomiasis (Chagas disease). Three different crystalline forms of PABZI [a solvent-free form (form I), three isostructural solvates (from isopropanol; acetonitrile-dichloromethane, and methanol-benzene) and a non-isostructural solvate from methanol] were isolated and characterized. The crystal structure of form I was resolved at 173 K and 300 K by single crystal X-ray diffraction. Physicochemical properties, including solubility, dissolution rate, wettability, and solid-state stability were assessed for the two most viable solid forms of PABZI, viz. form I and the isopropanol solvate (PABZI-isoOH). Form I exhibited a higher solubility and dissolution rate, and superior stability towards moisture (40 °C/75 % relative humidity) and UV-Visible light than PABZI-isoOH. Based on the solid-state stability results, form I was selected over PABZI-isoOH for further preclinical studies.


Assuntos
2-Propanol , Metanol , Cristalização , Solventes/química , Solubilidade , Acetamidas , Benzimidazóis , Difração de Raios X , Varredura Diferencial de Calorimetria
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA